Subscribe Now Subscribe Today
Science Alert
 
Blue
   
Curve Top
International Journal of Pharmacology
  Year: 2011 | Volume: 7 | Issue: 5 | Page No.: 579-588
DOI: 10.3923/ijp.2011.579.588
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Management of Non Alcoholic Fatty Liver Diseases and their Complications

J.A. Ansari, Mateen Sayyed and Faizan Sayeed

Abstract:
There is a rapid raise in the metabolic risk factors in the general population and non-alcoholic fatty liver disease has become the most common cause of liver disease worldwide. Early detection of hepatotoxicity is extremely important because continued ingestion of the drug is often associated with a poor prognosis. Insulin resistance play a central role in the pathogenesis of Non Alcoholic Fatty Liver Disease (NAFLD); thus obesity, diabetes and the metabolic syndrome are frequently associated with the disease. Consequently, as these metabolic conditions emerge as major health problems in Western society, it is now accepted that NAFLD is the most common chronic liver condition in the Western world. The pathogenesis of non-alcoholic fatty liver disease is not completely understood and even if insulin resistance is a chief pathogenetic key, many other factors are implicated in both liver fat accumulation and disease progression to non-alcoholic steatohepatitis. There is, as up till now no firm evidence-based treatment for NAFLD. Therapy is currently directed at treating components of the metabolic syndrome which may also be valuable for the liver. Management is further complex by the inability to predict which patients will develop liver-related morbidity and thus benefit from treatment. Data were located, selected and extracted from SCI database, Medline, Pubmed, Highwire and Google Scholar.
PDF Fulltext XML References Citation Report Citation
 RELATED ARTICLES:
  •    Protective Effect of Byrsonima sericea Extract on Non-alcoholic Fatty Liver Disease Model in Rats
  •    Pathways of Hepatic Regeneration and Pharmacological Approaches for Hepatoprotection: A Brief Approach
  •    The Promise of Traditional Medicines
  •    Therapeutic Approaches in Management of Drug-induced Hepatotoxicity
  •    A Brief Focus on Hepatoprotective Leads from Herbal Origin
How to cite this article:

J.A. Ansari, Mateen Sayyed and Faizan Sayeed, 2011. Management of Non Alcoholic Fatty Liver Diseases and their Complications. International Journal of Pharmacology, 7: 579-588.

DOI: 10.3923/ijp.2011.579.588

URL: https://scialert.net/abstract/?doi=ijp.2011.579.588

COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 

Curve Bottom